Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1472548

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1472548

LAMEA Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Cattle, and Sheep & Goats), By Vaccines Type, By Route of Administration, By Indication, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 137 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Ruminant Vaccines Market would witness market growth of 9.1% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Ruminant Vaccines Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $131.5 million by 2031. The Argentina market is showcasing a CAGR of 9.7% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 8.7% during (2024 - 2031).

Knowledge, awareness, and education are critical in driving producers' adoption of vaccination programs. Access to information about disease risks, vaccine efficacy, vaccination protocols, and best practices in herd health management empowers producers to make informed decisions about disease prevention strategies and vaccine use. Moreover, access to veterinary services, vaccine products, and support infrastructure influences the adoption of vaccination programs in ruminant populations.

Producers in remote or underserved areas may face challenges in accessing veterinary care, vaccine supplies, and technical expertise, which can impact their ability to implement vaccination effectively. The availability of cold chain infrastructure, vaccination equipment, and storage facilities affects vaccine delivery and administration in ruminant populations. Producers prioritize investment in infrastructure and logistics to ensure the quality and efficacy of vaccines and optimize vaccine coverage rates.

Leptospirosis is a widespread and economically significant bacterial disease affecting ruminants in Brazil. According to the National Library of Medicine, Brazil has the highest number of reported cases of leptospirosis in the region of the Americas. An average of 4,000 confirmed cases with a 10% case fatality are reported to the Ministry of Health (MOH). Most cases are among young adults between the ages of 20 and 49 years old. The high prevalence of leptospirosis drives the demand for effective vaccines among cattle producers in Brazil. Likewise, the UAE has many livestock, including sheep, goats, and camels. These animals are susceptible to various infectious diseases, including respiratory infections, gastrointestinal diseases, and vector-borne illnesses. A substantial number of cattle are present in the United Arab Emirates, according to the Ministry of Climate Change & Environment. It is estimated that 450,000 camels are present across the nation overall. In contrast, sheep and goat herds are estimated at 5 million, thus constituting an important component of food security and the national economy. Therefore, the high population of livestock and the prevalence of leptospirosis are driving the market's growth.

Based on Animal Type, the market is segmented into Cattle, and Sheep & Goats. Based on Vaccines Type, the market is segmented into Modified/ Attenuated Live, Inactivated (Killed), and Others. Based on Route of Administration, the market is segmented into Injectable, and Intranasal. Based on Indication, the market is segmented into Bovine Respiratory Diseases (BRD), Diarrhea/ Scours, FMD, Clostridial Diseases, Leptospirosis, BVD Infection, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Boehringer Ingelheim International GmbH
  • Zoetis, Inc.
  • Merck & Co., Inc.
  • Bimeda, Inc.
  • Elanco Animal Health, Inc.
  • Virbac
  • Ceva Sante Animale
  • CZ Vaccines S.A.U. (Zendal Health S.A.)
  • Indian Immunologicals Ltd. (National Dairy Development Board)
  • Vaxxinova International BV (EW Group)

LAMEA Ruminant Vaccines Market Report Segmentation

By Animal Type

  • Cattle
  • Sheep & Goats

By Vaccines Type

  • Modified/ Attenuated Live
  • Inactivated (Killed)
  • Others

By Route of Administration

  • Injectable
  • Intranasal

By Indication

  • Bovine Respiratory Diseases (BRD)
  • Diarrhea/ Scours
  • FMD
  • Clostridial Diseases
  • Leptospirosis
  • BVD Infection
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1LAMEA Ruminant Vaccines Market, by Animal Type
    • 1.4.2LAMEA Ruminant Vaccines Market, by Vaccines Type
    • 1.4.3LAMEA Ruminant Vaccines Market, by Route of Administration
    • 1.4.4LAMEA Ruminant Vaccines Market, by Indication
    • 1.4.5LAMEA Ruminant Vaccines Market, by Country
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Opportunities
    • 3.2.3Market Restraints
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.Recent strategies deployed in Ruminant Vaccines Market

Chapter 5.LAMEA Ruminant Vaccines Market by Animal Type

  • 5.1LAMEA Cattle Market by Country
  • 5.2LAMEA Sheep & Goats Market by Country

Chapter 6.LAMEA Ruminant Vaccines Market by Vaccines Type

  • 6.1LAMEA Modified/ Attenuated Live Market by Country
  • 6.2LAMEA Inactivated (Killed) Market by Country
  • 6.3LAMEA Others Market by Country

Chapter 7.LAMEA Ruminant Vaccines Market by Route of Administration

  • 7.1LAMEA Injectable Market by Country
  • 7.2LAMEA Intranasal Market by Country

Chapter 8.LAMEA Ruminant Vaccines Market by Indication

  • 8.1LAMEA Bovine Respiratory Diseases (BRD) Market by Country
  • 8.2LAMEA Diarrhea/ Scours Market by Country
  • 8.3LAMEA FMD Market by Country
  • 8.4LAMEA Clostridial Diseases Market by Country
  • 8.5LAMEA Leptospirosis Market by Country
  • 8.6LAMEA BVD Infection Market by Country
  • 8.7LAMEA Others Market by Country

Chapter 9.LAMEA Ruminant Vaccines Market by Country

  • 9.1Brazil Ruminant Vaccines Market
    • 9.1.1Brazil Ruminant Vaccines Market by Animal Type
    • 9.1.2Brazil Ruminant Vaccines Market by Vaccines Type
    • 9.1.3Brazil Ruminant Vaccines Market by Route of Administration
    • 9.1.4Brazil Ruminant Vaccines Market by Indication
  • 9.2Argentina Ruminant Vaccines Market
    • 9.2.1Argentina Ruminant Vaccines Market by Animal Type
    • 9.2.2Argentina Ruminant Vaccines Market by Vaccines Type
    • 9.2.3Argentina Ruminant Vaccines Market by Route of Administration
    • 9.2.4Argentina Ruminant Vaccines Market by Indication
  • 9.3UAE Ruminant Vaccines Market
    • 9.3.1UAE Ruminant Vaccines Market by Animal Type
    • 9.3.2UAE Ruminant Vaccines Market by Vaccines Type
    • 9.3.3UAE Ruminant Vaccines Market by Route of Administration
    • 9.3.4UAE Ruminant Vaccines Market by Indication
  • 9.4Saudi Arabia Ruminant Vaccines Market
    • 9.4.1Saudi Arabia Ruminant Vaccines Market by Animal Type
    • 9.4.2Saudi Arabia Ruminant Vaccines Market by Vaccines Type
    • 9.4.3Saudi Arabia Ruminant Vaccines Market by Route of Administration
    • 9.4.4Saudi Arabia Ruminant Vaccines Market by Indication
  • 9.5South Africa Ruminant Vaccines Market
    • 9.5.1South Africa Ruminant Vaccines Market by Animal Type
    • 9.5.2South Africa Ruminant Vaccines Market by Vaccines Type
    • 9.5.3South Africa Ruminant Vaccines Market by Route of Administration
    • 9.5.4South Africa Ruminant Vaccines Market by Indication
  • 9.6Nigeria Ruminant Vaccines Market
    • 9.6.1Nigeria Ruminant Vaccines Market by Animal Type
    • 9.6.2Nigeria Ruminant Vaccines Market by Vaccines Type
    • 9.6.3Nigeria Ruminant Vaccines Market by Route of Administration
    • 9.6.4Nigeria Ruminant Vaccines Market by Indication
  • 9.7Rest of LAMEA Ruminant Vaccines Market
    • 9.7.1Rest of LAMEA Ruminant Vaccines Market by Animal Type
    • 9.7.2Rest of LAMEA Ruminant Vaccines Market by Vaccines Type
    • 9.7.3Rest of LAMEA Ruminant Vaccines Market by Route of Administration
    • 9.7.4Rest of LAMEA Ruminant Vaccines Market by Indication

Chapter 10.Company Profiles

  • 10.1Boehringer Ingelheim International GmbH
    • 10.1.1Company Overview
    • 10.1.2Financial Analysis
    • 10.1.3Regional & Segmental Analysis
    • 10.1.4Research & Development Expenses
    • 10.1.5Recent strategies and developments:
      • 10.1.5.1Partnerships, Collaborations, and Agreements:
      • 10.1.5.2Product Launches and Product Expansions:
      • 10.1.5.3Geographical Expansions:
    • 10.1.6SWOT Analysis
  • 10.2Zoetis, Inc.
    • 10.2.1Company Overview
    • 10.2.2Financial Analysis
    • 10.2.3Regional Analysis
    • 10.2.4Research & Development Expenses
    • 10.2.5Recent strategies and developments:
      • 10.2.5.1Product Launches and Product Expansions:
    • 10.2.6SWOT Analysis
  • 10.3Merck & Co., Inc.
    • 10.3.1Company Overview
    • 10.3.2Financial Analysis
    • 10.3.3Segmental and Regional Analysis
    • 10.3.4Research & Development Expenses
    • 10.3.5Recent strategies and developments:
      • 10.3.5.1Product Launches and Product Expansions:
    • 10.3.6SWOT Analysis
  • 10.4Bimeda, Inc.
    • 10.4.1Company Overview
    • 10.4.2SWOT Analysis
  • 10.5Elanco Animal Health, Inc.
    • 10.5.1Company Overview
    • 10.5.2Financial Analysis
    • 10.5.3Regional Analysis
    • 10.5.4Research & Development Expenses
    • 10.5.5SWOT Analysis
  • 10.6Virbac
    • 10.6.1Company Overview
    • 10.6.2Financial Analysis
    • 10.6.3Regional Analysis
    • 10.6.4SWOT Analysis
  • 10.7Ceva Sante Animale
    • 10.7.1Company Overview
    • 10.7.2Recent strategies and developments:
      • 10.7.2.1Acquisition and Mergers:
    • 10.7.3SWOT Analysis
  • 10.8CZ Vaccines S.A.U. (Zendal Health S.A.)
    • 10.8.1Company Overview
    • 10.8.2SWOT Analysis
  • 10.9Indian Immunologicals Ltd. (National Dairy Development Board)
    • 10.9.1Company Overview
    • 10.9.2Financial Analysis
    • 10.9.3Research & Development Expenses
    • 10.9.4SWOT Analysis
  • 10.10.Vaxxinova International BV (EW Group)
    • 10.10.1Company Overview
    • 10.10.2SWOT Analysis

LIST OF TABLES

  • TABLE 1LAMEA Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 2LAMEA Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 3LAMEA Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 4LAMEA Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 5LAMEA Cattle Market by Country, 2020 - 2023, USD Million
  • TABLE 6LAMEA Cattle Market by Country, 2024 - 2031, USD Million
  • TABLE 7LAMEA Sheep & Goats Market by Country, 2020 - 2023, USD Million
  • TABLE 8LAMEA Sheep & Goats Market by Country, 2024 - 2031, USD Million
  • TABLE 9LAMEA Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 10LAMEA Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 11LAMEA Modified/ Attenuated Live Market by Country, 2020 - 2023, USD Million
  • TABLE 12LAMEA Modified/ Attenuated Live Market by Country, 2024 - 2031, USD Million
  • TABLE 13LAMEA Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
  • TABLE 14LAMEA Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
  • TABLE 15LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 16LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 17LAMEA Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 18LAMEA Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 19LAMEA Injectable Market by Country, 2020 - 2023, USD Million
  • TABLE 20LAMEA Injectable Market by Country, 2024 - 2031, USD Million
  • TABLE 21LAMEA Intranasal Market by Country, 2020 - 2023, USD Million
  • TABLE 22LAMEA Intranasal Market by Country, 2024 - 2031, USD Million
  • TABLE 23LAMEA Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 24LAMEA Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 25LAMEA Bovine Respiratory Diseases (BRD) Market by Country, 2020 - 2023, USD Million
  • TABLE 26LAMEA Bovine Respiratory Diseases (BRD) Market by Country, 2024 - 2031, USD Million
  • TABLE 27LAMEA Diarrhea/ Scours Market by Country, 2020 - 2023, USD Million
  • TABLE 28LAMEA Diarrhea/ Scours Market by Country, 2024 - 2031, USD Million
  • TABLE 29LAMEA FMD Market by Country, 2020 - 2023, USD Million
  • TABLE 30LAMEA FMD Market by Country, 2024 - 2031, USD Million
  • TABLE 31LAMEA Clostridial Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 32LAMEA Clostridial Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 33LAMEA Leptospirosis Market by Country, 2020 - 2023, USD Million
  • TABLE 34LAMEA Leptospirosis Market by Country, 2024 - 2031, USD Million
  • TABLE 35LAMEA BVD Infection Market by Country, 2020 - 2023, USD Million
  • TABLE 36LAMEA BVD Infection Market by Country, 2024 - 2031, USD Million
  • TABLE 37LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 38LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 39LAMEA Ruminant Vaccines Market by Country, 2020 - 2023, USD Million
  • TABLE 40LAMEA Ruminant Vaccines Market by Country, 2024 - 2031, USD Million
  • TABLE 41Brazil Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 42Brazil Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 43Brazil Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 44Brazil Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 45Brazil Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 46Brazil Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 47Brazil Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 48Brazil Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 49Brazil Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 50Brazil Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 51Argentina Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 52Argentina Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 53Argentina Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 54Argentina Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 55Argentina Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 56Argentina Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 57Argentina Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 58Argentina Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 59Argentina Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 60Argentina Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 61UAE Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 62UAE Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 63UAE Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 64UAE Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 65UAE Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 66UAE Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 67UAE Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 68UAE Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 69UAE Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 70UAE Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 71Saudi Arabia Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 72Saudi Arabia Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 73Saudi Arabia Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 74Saudi Arabia Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 75Saudi Arabia Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 76Saudi Arabia Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 77Saudi Arabia Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 78Saudi Arabia Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 79Saudi Arabia Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 80Saudi Arabia Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 81South Africa Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 82South Africa Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 83South Africa Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 84South Africa Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 85South Africa Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 86South Africa Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 87South Africa Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 88South Africa Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 89South Africa Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 90South Africa Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 91Nigeria Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 92Nigeria Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 93Nigeria Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 94Nigeria Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 95Nigeria Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 96Nigeria Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 97Nigeria Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 98Nigeria Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 99Nigeria Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 100Nigeria Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 101Rest of LAMEA Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 102Rest of LAMEA Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 103Rest of LAMEA Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 104Rest of LAMEA Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 105Rest of LAMEA Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 106Rest of LAMEA Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 107Rest of LAMEA Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 108Rest of LAMEA Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 109Rest of LAMEA Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 110Rest of LAMEA Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 111Key Information - Boehringer Ingelheim International GmbH
  • TABLE 112Key Information - Zoetis, Inc.
  • TABLE 113Key Information - Merck & Co., Inc.
  • TABLE 114Key Information - Bimeda, Inc.
  • TABLE 115Key information - Elanco Animal Health, Inc.
  • TABLE 116Key Information - Virbac
  • TABLE 117Key Information - Ceva SantE Animale
  • TABLE 118Key Information - CZ Vaccines S.A.U.
  • TABLE 119Key Information - Indian Immunologicals Ltd.
  • TABLE 120Key Information - Vaxxinova International BV
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!